DIOGENO
We help companies of any size build and execute mobile and web projects, through consultative advice and hands-on resources.
DIOGENO
Industry:
Apps Consulting Internet Mobile
Founded:
2016-06-01
Address:
Barcelona, Catalonia, Spain
Country:
Spain
Website Url:
http://www.diogeno.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Analytics Content Delivery Network Google Universal Analytics Font Awesome Google Apps For Business JsDelivr BootstrapCDN
Founder
Official Site Inspections
http://www.diogeno.com
- Host name: webredir.vip.gandi.net
- IP address: 217.70.184.38
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "Diogeno"
Home - DioGenX
Nov 12, 2024 DiogenX is a preclinical stage biotech company committed to a single mission: to discover and develop innovative biologics as new …See details»
About us - DioGenX
The company is developing first-in-class recombinant proteins designed for the treatment of T1D. DiogenX’s lead program DGX-01 modulates the Wnt/β-catenin signalling pathway to …See details»
Our approach - DioGenX
In this context, DiogenX’s approach has a unique off-the shelf profile for symptomatic T1D patients. With the potential to regenerate the patient’s own beta cell and restore its own pancreatic function, DiogenX’s lead candidate could …See details»
DiogenX - Products, Competitors, Financials, Employees, …
About DiogenX. DiogenX is a preclinical stage biotech company focused on developing biologics as therapeutic options for diabetes. The company is involved in research to develop a …See details»
Scientific Advisor and co-Founder at DiogenX - The Org
Patrick is currently serving as a Scientific Advisor and co-Founder at DiogenX since January 2020. Prior to this, they worked at INSERM as a Team Leader since 2009. Patrick also gained …See details»
DiogenX - Recent News & Activity - Crunchbase
Organization. DiogenX . Connect to CRM . Save . Go back to DiogenX's Summary . Recent News & Activity. Edit Recent News & Activity Section. News • Nov 12, 2024. PharmiWeb.com — …See details»
DiogenX raises $30M for regenerative diabetes treatment
May 12, 2023 DiogenX announced that it completed a $30 million Series A financing round to support its regenerating insulin-producing beta cells. Marseille, France-based DiogenX aims to use the funds to advance its lead drug …See details»
DiogenX raises €27.5M Series A financing to advance …
May 10, 2023 DiogenX previously raised €4.5M ($4.8M) in June 2020. ... The T1D Fund invests in areas strategically aligned with JDRF, the leading global organization funding T1D research, with an exclusive focus on supporting the …See details»
Invest In DiogenX Stock | Buy Pre-IPO Shares - EquityZen
May 14, 2023 DiogenX is a preclinical stage biotech company, specializing in the development of pancreatic beta-cell modulators for the treatment of Type 1 (T1D) and Type 2 Diabetes …See details»
DiogenX appoints Dr. Klara Owen as Chief Medical Officer
DiogenX’s lead program DGX-01 modulates the Wnt/β-catenin signalling pathway to regenerate insulin-producing pancreatic beta cells to offer a disease-modifying therapy for T1D. This …See details»
DiogenX raises €27.5M for “breakthrough” diabetes …
May 12, 2023 DiogenX, a biotech company focused on regenerating insulin-producing beta cells for the treatment of diabetes, has announced the successful completion of a €27.5 million ($30 million) Series A financing round.. New …See details»
Ce chercheur veut améliorer la vie des patients atteints du diabète …
Feb 25, 2024 Avec la start-up DiogenX créée en 2019 et pour laquelle il est consultant, Patrick Collombat met les bouchées doubles. "Nous avons une dizaine de personnes qui travaillent ici …See details»
News - DioGenX
Jun 16, 2020 DiogenX Raises €4.5M in Seed Financing from Advent France Biotechnology, Boehringer Ingelheim Venture Fund and JDRF T1D Fund June 16, 2020 Events. 12/11/2024; …See details»
DiogenX incorpora a su plantilla a Hélène Sicard como
Jul 25, 2024 DiogenX refuerza su comité ejecutivo. La empresa de biotecnología centrada en la regeneración de células beta productoras de insulina para el tratamiento de la diabetes, ha …See details»
[Biotech] DiogenX (Marseille) finalise une levée de fonds de 27,5 ...
May 10, 2023 DiogenX, société de biotechnologie spécialisée dans la régénération des cellules bêta productrices d’insuline pour le traitement du diabète, annonce aujourd’hui avoir finalisé …See details»
McDermott Advises DiogenX in Series A financing Round
May 15, 2023 DiogenX is raising EUR27.5 million to advance its lead program into Phase I in Type 1 diabetes patients. New investors Roche Venture Fund, Eli Lilly and Company and …See details»
DiogenX lève 27,5 millions d’euros lors d’un tour de financement …
May 11, 2023 DiogenX, société de biotechnologie spécialisée dans la régénération des cellules bêta productrices d’insuline pour le traitement du diabète, a annoncé avoir finalisé un tour de …See details»
Biotech : sorti de la recherche d’UCA sur le diabète, DiogenX lève …
Startup fondée en 2020 sur les travaux de Patrick Collombat, responsable de l’équipe de recherche “génétique du diabète” à l’université de Nice, DiogenX vient de réussir un second …See details»
Filipe Nobrega, Author at DioGenX
DiogenX raises €27.5M Series A financing to advance its first-in-class regenerative treatment for type 1 diabetes into clinical trial May 10, 2023 DiogenX Raises €4.5M in Seed Financing from …See details»
DiogenX lève 4,5 millions d'euros en amorçage auprès d'Advent …
Jun 17, 2020 DiogenX, une société de biotechnologie au stade préclinique spécialisée dans le développement de modulateurs des cellules bêta pancréatiques pour le traitement du diabète …See details»